Literature DB >> 23167905

Frequency of self-adjustment of insulin dose and metabolic control in Type 2 diabetes -is there an association?

E Beluchin1, L Bäz, N Müller, T Lehmann, C Kloos, G Wolf, U A Müller.   

Abstract

AIM: To investigate the supposition that self-adjustment of insulin dose will improve metabolic control in patients with Type 2 diabetes.
METHODS: The number of self-adjustments of insulin dose was checked in a cross-sectional study involving 300 patients with Type 2 diabetes in a university outpatient department, who were insulin treated.
RESULTS: One hundred and ninety-three patients (64%) performed insulin dose adjustments at least once in 14 days. The mean number of dose adjustments was 17.4 per 14 days. Patients with self-adjustments of insulin dose were younger (65.6 vs. 68.9 years), had a higher social status score (11.1 vs. 9.8) and a higher insulin dose (68.8 vs. 53.6 IU/day) than patients without dose adjustments. Each insulin dose adjustment was associated with an HbA(1c) decrease of 0.016% (P = 0.004). Any additional blood glucose self measurement was associated with an HbA(1c) increase of 0.019% (P = 0.038).
CONCLUSIONS: Two-thirds of patients with Type 2 diabetes, who have undergone training in how to manage their condition, practise insulin dose self-adjustments. A weak association was observed between insulin dose adjustments and HbA(1c).
© 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23167905     DOI: 10.1111/dme.12071

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  2 in total

1.  A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.

Authors:  Michael A Nauck; Burkhard Haastert; Christoph Trautner; Ulrich A Müller; Matthias A Nauck; Lutz Heinemann
Journal:  Diabetologia       Date:  2014-01-21       Impact factor: 10.122

2.  An educational program for insulin self-adjustment associated with structured self-monitoring of blood glucose significantly improves glycemic control in patients with type 2 diabetes mellitus after 12 weeks: a randomized, controlled pilot study.

Authors:  Daniel Dutra Romualdo Silva; Adriana Aparecida Bosco
Journal:  Diabetol Metab Syndr       Date:  2015-01-15       Impact factor: 3.320

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.